Bio-Techne Corporation
TECH
Classement en actions
#1874
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Prix de l'action
$72.55
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$11.38B
Changement (1 jour)
0.03%
Changement (1 an)
17.27%
Pays
US
Échange Bio-Techne Corporation (TECH)
Catégorie
Healthcare
Historique des dividendes pour Bio-Techne Corporation (TECH)
Bio-Techne Corporation (symbole boursier : TECH) a versé un total de 70 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $5.35
Rendement du dividende (TTM) : 0.0044
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $5.35
Rendement du dividende (TTM) : 0.0044
Versements de dividendes pour Bio-Techne Corporation (TECH) de 2008 à 2026
Versements annuels de dividendes
| Année | Dividende (ajusté pour divisions d’actions) | Changez |
|---|---|---|
| 2026 (TTM) | $0.08 | -75.00% |
| 2025 | $0.32 | 0.00% |
| 2024 | $0.32 | 0.00% |
| 2023 | $0.32 | 0.00% |
| 2022 | $0.32 | 0.00% |
| 2021 | $0.32 | 0.00% |
| 2020 | $0.32 | 0.00% |
| 2019 | $0.32 | 0.00% |
| 2018 | $0.32 | 0.00% |
| 2017 | $0.32 | 0.00% |
| 2016 | $0.32 | 0.00% |
| 2015 | $0.32 | 2.40% |
| 2014 | $0.3125 | 3.31% |
| 2013 | $0.3025 | 6.14% |
| 2012 | $0.285 | 4.59% |
| 2011 | $0.2725 | 3.81% |
| 2010 | $0.2625 | 3.96% |
| 2009 | $0.2525 | 304.00% |
| 2008 | $0.0625 | 0.00% |
Liste de tous les paiements de dividendes
| Année | Dividende | Changez |
|---|---|---|
| 2026 (TTM) | $0.08 | -75.00% |
| 2025 | $0.32 | 0.00% |
| 2024 | $0.32 | 0.00% |
| 2023 | $0.32 | -75.00% |
| 2022 | $1.28 | 0.00% |
| 2021 | $1.28 | 0.00% |
| 2020 | $1.28 | 0.00% |
| 2019 | $1.28 | 0.00% |
| 2018 | $1.28 | 0.00% |
| 2017 | $1.28 | 0.00% |
| 2016 | $1.28 | 0.00% |
| 2015 | $1.28 | 2.40% |
| 2014 | $1.25 | 3.31% |
| 2013 | $1.21 | 6.14% |
| 2012 | $1.14 | 4.59% |
| 2011 | $1.09 | 3.81% |
| 2010 | $1.05 | 3.96% |
| 2009 | $1.01 | 304.00% |
| 2008 | $0.25 | 0.00% |
Dividendes versés par des entreprises similaires ou concurrentes
| Entreprise | Nombre de paiements de dividendes | Pays |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
